Skip to content

Comparison of GnRHa and mifepristone in the treatment of symptomatic endometriosis

Comparison of GnRHa and mifepristone in the treatment of symptomatic endometriosis

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000031689
Enrollment
Unknown
Registered
2020-04-07
Start date
2020-04-01
Completion date
Unknown
Last updated
2020-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Interventions

Sponsors

Department of Gynecology and Obstetrics Hospital Affiliated to Zhejiang University Medical College
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Female, over 18 years old, who agree to use GnRHa and mifepristone for treatment and sign the informed consent; 2. Patients with endometriosis confirmed by outpatient or ward auxiliary examination such as B-ultrasound and / or magnetic resonance imaging (MRI) should not be operated temporarily, or diagnosed as endometriosis by pathology after operation; 3. Dysmenorrhea with or without menorrhagia; 4. Patients who request to keep the uterus or give birth; 5. Patients who did not receive other hormone drugs for endometriosis within 3 months before the drug treatment; 6. Patients with normal or non clinically significant cervical cytology results (results within 6 months before screening period).

Exclusion criteria

Exclusion criteria: 1. Patients with pelvic pain, vaginal bleeding and other symptoms caused by unknown or non endometriosis; 2. Patients diagnosed as endometrial polyp, submucous myoma and other benign lesions or suspicious malignant tumors by B-ultrasound; 3. Patients receiving other hormone drugs for endometriosis; 4. Patients who are using other drugs that interact with the study drug and cannot stop the drug; 5. Patients with serious heart, liver and kidney diseases and adrenal cortex dysfunction; patients with drug allergy or allergic constitution; 6. Patients who have participated in other clinical trials within 3 months and who other personnel think are not suitable to participate in the trial. 7. Patients with fertility requirements have poor ovarian reserve function: basic endocrine FSH > 10iu / L, the number of follicles in bilateral sinuses is less than 3-5, AMH < 1.1ng/ml.

Design outcomes

Primary

MeasureTime frame
pain score;change of menstrual volume;the level of CA125;lesion size;liver function;blood lipid level;reproductive hormone level;endometrial thickness;

Countries

China

Contacts

Public ContactXinmei Zhang

Department of Gynecology and Obstetrics Hospital affiliated to Zhejiang University Medical College

zxm20130729@163.com+86 18957110072

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026